Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

The device improved hair growth and thickness in men without side effects.

General anesthesia might be linked to certain types of hair loss, but more research is needed.

Low-dose oral minoxidil is safe for treating children's hair disorders.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Topical minoxidil and oral finasteride are effective for managing hair loss.

New treatments for hair loss are being developed.

Recurrent furunculosis can be managed with antibiotics, decolonization, and decontamination, with potential future use of vaccines and bacteriophage therapy.

Dermatologists should be involved in the care of hematology patients due to common skin issues.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

The follicular unit extraction method for hair transplants is a technique with benefits and drawbacks.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Furunculosis is a recurring skin infection needing careful hygiene and treatment to manage and prevent spread.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Low-dose oral minoxidil can be effective for hair loss but should be avoided in people with certain heart conditions and severe liver problems.

Monocytes might be linked to hair loss after COVID-19.

Androgenetic alopecia severity does not affect COVID-19 severity.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Two newborns with rare skin infections were successfully treated with antifungal cream.

A woman's COVID-19 related hair loss improved after using a specific hair care routine for 30 days.

Alopecia areata affects 1.45% of people in Japan, impacting mood and self-esteem, with many not seeking treatment.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.